Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02917707

Integrative Analysis of CRC Liver Metastasis

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Da Fu · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators will perform integrative analysis of CRC liver metastasis

Detailed description

The investigators will analyzed proteomes of paired normal colorectal tissues and colorectal cancer (CRC) with or without liver metastasis, sequenced transcriptomes, performed whole exome sequencing, and single nucleotide polymorphism (SNP) array profiling for triplets, each comprising normal colorectal tissue, primary colorectal carcinoma, and its synchronous matched liver metastasis, as well as analyzed genomics of CRC characterized previously by The Cancer Genome Atlas (TCGA) to conduct integrated proteogenomic analyses.

Conditions

Interventions

TypeNameDescription
OTHERnormal colorectal tissuesThe investigators will extract total protein, DNA and RNA from these groups.

Timeline

Start date
2016-01-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2016-09-28
Last updated
2016-09-28

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02917707. Inclusion in this directory is not an endorsement.

Integrative Analysis of CRC Liver Metastasis (NCT02917707) · Clinical Trials Directory